Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2006):

Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase.

Full Abstract

Narrow-band UVB has been reported to be efficacious in patients with vitiligo. The epidermis of patients with vitiligo showed reduction in the levels of catalase, in association with high levels of hydrogen peroxidase (H2O2) that is toxic for melanocytes. Based on these findings, we studied the efficacy and safety of a topical gel containing catalase and superoxide dismutase (Vitix) in combination with narrow-band UVB. The study included 22 patients of which 19 completed the 6-month study period. Patients applied the gel containing catalase and superoxide dismutase twice a day and received narrow-band UVB 3 times per week. Two different dermatologists evaluated the grade of repigmentation by photograph comparison. At the end of therapy, more than 50% of overall repigmentation was noticed in 11 of 19 (57.9%) patients. More than 75% repigmentation was recorded in three (15.79%), 26%-50% repigmentation in six (31.58%) patients and 1%-25% repigmentation in one (5.26%) patient, whereas one (5.26%) of 19 patients showed no repigmentation at all. The best response was achieved on the face and neck, with more than 50% repigmentation observed in 11 of 14 (78.6%) patients. Development of new lesions was not observed. Adverse events were mild and transient. The study showed that the combination therapy of narrow-band UVB and gel containing catalase and dismutase is a therapeutic option that could be considered in the management of vitiligo. Further evaluation of this combination in multicenter, double-blind, placebo-controlled studies should be undertaken.

 

Author information

Author/s: Kostovic, Kresimir (K); Pastar, Zrinjka (Z); Pasic, Aida (A); Ceovic, Romana (R);

Affiliation: Department of Dermatology and Venereology, Zagreb University Hospital Center, Salata 4, HR-10000 Zagreb Croatia. kreso.kostovic(-atsign-)zg.htnet.hr

Journal and publication information

Publication Type: Clinical Trial; Journal Article

Journal: Acta dermatovenerologica Croatica : ADC / Hrvatsko dermatolosko drustvo (Acta Dermatovenerol Croat), published in Croatia. (Language: eng)

Reference: 2007-; vol 15 (issue 1) : pp 10-4

Dates: Created 2007/04/16; Completed 2007/08/08;

PMID: 17433173, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Antioxidants (0) ; Vitix (0) ; Catalase (EC 1.11.1.6) ; Superoxide Dismutase (EC 1.15.1.1)

Related articles

These are the most related articles currently in our database:

See 100+ related articles.

Related Article Map

12/30/1985
6/23/2008
Higher Relevance Score (37)
Lower Relevance Score (22)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.

© Advanogy LLC 2003-2010 - All rights reserved. Terms of Use | Contact Us | Index